Cargando…

Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia

BACKGROUND: Despite the fact that adherence to antipsychotic medications is the cornerstone in the treatment and prevention of relapse of the disease, non-adherence is a major problem among schizophrenia patients. The purpose of this study was to assess the magnitude and factors associated with anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Tareke, Minale, Tesfaye, Siranesh, Amare, Desalegn, Belete, Tilahun, Abate, Andargie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138084/
https://www.ncbi.nlm.nih.gov/pubmed/30263211
http://dx.doi.org/10.4102/sajpsychiatry.v24i0.1124
_version_ 1783355282847432704
author Tareke, Minale
Tesfaye, Siranesh
Amare, Desalegn
Belete, Tilahun
Abate, Andargie
author_facet Tareke, Minale
Tesfaye, Siranesh
Amare, Desalegn
Belete, Tilahun
Abate, Andargie
author_sort Tareke, Minale
collection PubMed
description BACKGROUND: Despite the fact that adherence to antipsychotic medications is the cornerstone in the treatment and prevention of relapse of the disease, non-adherence is a major problem among schizophrenia patients. The purpose of this study was to assess the magnitude and factors associated with antipsychotic medication non-adherence among schizophrenia patients in Amanuel Mental Specialized Hospital. METHOD: An institution-based cross-sectional study was conducted among 412 people with schizophrenia at Amanuel Mental Specialized Hospital from April to May 2014. Non-adherence was assessed using the questionnaire of Morisky medication adherence rating scale and semi-structured questions for assessment of associated factors. Logistic regression analysis was used to assess predictors of non-adherence. RESULTS: Prevalence of non-adherence was 41.0% among schizophrenia patients. Living in rural areas (adjusted odds ratio [AOR] = 2.07; 95% confidence interval [CI]: 1.31, 3.28), current substance use (AOR = 1.67; 95% CI: 1.09, 2.56), long duration of treatment (AOR = 2.07; 95% CI: 1.22, 3.50) and polypharmacy (AOR = 2.13; 95% CI: 1.34, 3.40) were found to be significantly associated with non-adherence. CONCLUSION: The results indicate that non-adherence to antipsychotic medication was a major problem among patients with schizophrenia. Reducing the number of antipsychotic medications and availing drugs in rural areas may decrease the level of non-adherence.
format Online
Article
Text
id pubmed-6138084
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher AOSIS
record_format MEDLINE/PubMed
spelling pubmed-61380842018-09-27 Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia Tareke, Minale Tesfaye, Siranesh Amare, Desalegn Belete, Tilahun Abate, Andargie S Afr J Psychiatr Original Research BACKGROUND: Despite the fact that adherence to antipsychotic medications is the cornerstone in the treatment and prevention of relapse of the disease, non-adherence is a major problem among schizophrenia patients. The purpose of this study was to assess the magnitude and factors associated with antipsychotic medication non-adherence among schizophrenia patients in Amanuel Mental Specialized Hospital. METHOD: An institution-based cross-sectional study was conducted among 412 people with schizophrenia at Amanuel Mental Specialized Hospital from April to May 2014. Non-adherence was assessed using the questionnaire of Morisky medication adherence rating scale and semi-structured questions for assessment of associated factors. Logistic regression analysis was used to assess predictors of non-adherence. RESULTS: Prevalence of non-adherence was 41.0% among schizophrenia patients. Living in rural areas (adjusted odds ratio [AOR] = 2.07; 95% confidence interval [CI]: 1.31, 3.28), current substance use (AOR = 1.67; 95% CI: 1.09, 2.56), long duration of treatment (AOR = 2.07; 95% CI: 1.22, 3.50) and polypharmacy (AOR = 2.13; 95% CI: 1.34, 3.40) were found to be significantly associated with non-adherence. CONCLUSION: The results indicate that non-adherence to antipsychotic medication was a major problem among patients with schizophrenia. Reducing the number of antipsychotic medications and availing drugs in rural areas may decrease the level of non-adherence. AOSIS 2018-03-05 /pmc/articles/PMC6138084/ /pubmed/30263211 http://dx.doi.org/10.4102/sajpsychiatry.v24i0.1124 Text en © 2018. The Authors https://creativecommons.org/licenses/by/4.0/ Licensee: AOSIS. This work is licensed under the Creative Commons Attribution License.
spellingShingle Original Research
Tareke, Minale
Tesfaye, Siranesh
Amare, Desalegn
Belete, Tilahun
Abate, Andargie
Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
title Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
title_full Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
title_fullStr Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
title_full_unstemmed Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
title_short Antipsychotic medication non-adherence among schizophrenia patients in Central Ethiopia
title_sort antipsychotic medication non-adherence among schizophrenia patients in central ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6138084/
https://www.ncbi.nlm.nih.gov/pubmed/30263211
http://dx.doi.org/10.4102/sajpsychiatry.v24i0.1124
work_keys_str_mv AT tarekeminale antipsychoticmedicationnonadherenceamongschizophreniapatientsincentralethiopia
AT tesfayesiranesh antipsychoticmedicationnonadherenceamongschizophreniapatientsincentralethiopia
AT amaredesalegn antipsychoticmedicationnonadherenceamongschizophreniapatientsincentralethiopia
AT beletetilahun antipsychoticmedicationnonadherenceamongschizophreniapatientsincentralethiopia
AT abateandargie antipsychoticmedicationnonadherenceamongschizophreniapatientsincentralethiopia